| 2025 | Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in Bleeding and Cardiovascular Events in Acute Coronary Syndrome Patients According to Renal Function: The Subanalysis From the TICO Trial
| KOREAN CIRCULATION JOURNAL |
| 2025 | Validation of Intravascular Ultrasound–Defined Optimal Stent Expansion Criteria for Favorable 1-Year Clinical Outcomes | JACC-CARDIOVASCULAR INTERVENTIONS |
| 2025 | Prognostic Implication of LDL-C Variability and Its Association with Lipid-Lowering Strategies: Insights from the RACING and LODESTAR Trials
| YONSEI MEDICAL JOURNAL |
| 2025 | Comparison of High-Dose versus Low-Dose Paclitaxel Drug-Coated Balloons for Native Femoropopliteal Artery Disease: An Analysis of the K-VIS ELLA Registry
| YONSEI MEDICAL JOURNAL |
| 2025 | Intravascular Ultrasound Predictors of 12-Month Patency Loss Following Drug-Coated Balloon Angioplasty for the Femoropopliteal Artery | AMERICAN JOURNAL OF CARDIOLOGY |
| 2025 | Prognostic implication of venoarterial extracorporeal membrane oxygenation in acute myocardial infarction-related cardiogenic shock | JOURNAL OF INTENSIVE CARE |
| 2025 | Ticagrelor monotherapy for acute coronary syndromes - Authors' reply | LANCET |
| 2025 | De-escalating Dual Antiplatelet Therapy to Ticagrelor Monotherapy in Acute Coronary Syndrome : A Systematic Review and Individual Patient Data Meta-analysis of Randomized Clinical Trials | ANNALS OF INTERNAL MEDICINE |
| 2025 | Endovascular Aneurysmal Repair With the INCRAFT Stent Graft System for Abdominal Aortic Aneurysms: A Combined Korean Multi-Center and Single-Center Registry Analysis | JOURNAL OF ENDOVASCULAR THERAPY |
| 2025 | Continuous Renal Replacement Therapy and Extracorporeal Membrane Oxygenation in Patients with Cardiogenic Shock: Results from the Rescue Registry
| JOURNAL OF CLINICAL MEDICINE |
| 2025 | Alternative LDL Cholesterol-Lowering Strategy vs High-Intensity Statins in Atherosclerotic Cardiovascular Disease: A Systematic Review and Individual Patient Data Meta-Analysis | JAMA CARDIOLOGY |
| 2025 | Potent P2Y12 Inhibitor Monotherapy for Acute Coronary Syndrome
| CIRCULATION JOURNAL |
| 2025 | Combination therapy with moderate-intensity atorvastatin and ezetimibe vs. high-intensity atorvastatin monotherapy in patients treated with percutaneous coronary intervention in practice: assessing RACING generalizability
| EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY |
| 2024 | Remnant cholesterol as a residual risk in atherosclerotic cardiovascular disease patients under statin-based lipid-lowering therapy: A post hoc analysis of the RACING trial | JOURNAL OF CLINICAL LIPIDOLOGY |
| 2024 | Development of Clinically Validated Artificial fi cial Intelligence Model for Detecting ST-segment Elevation Myocardial Infarction | ANNALS OF EMERGENCY MEDICINE |
| 2024 | Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Stent Implantation
| JOURNAL OF THE AMERICAN HEART ASSOCIATION |
| 2024 | De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials | LANCET |
| 2024 | Geographical Variations in the Effectiveness and Safety of Abbreviated or Standard Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients at High Bleeding Risk | CANADIAN JOURNAL OF CARDIOLOGY |
| 2024 | Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea | LANCET |
| 2024 | Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials | EUROPEAN HEART JOURNAL |
| 2024 | Clinical Outcomes After Drug-Coated Balloon Treatment in Popliteal Artery Disease: K-POP Registry 12-Month Results
| KOREAN CIRCULATION JOURNAL |
| 2024 | Effect of rosuvastatin versus atorvastatin on new-onset diabetes mellitus in patients treated with high-intensity statin therapy for coronary artery disease: a post-hoc analysis from the LODESTAR randomized clinical trial
| CARDIOVASCULAR DIABETOLOGY |
| 2024 | Predictive value of plaque characteristics for identification of lesions causing ischemia | INTERNATIONAL JOURNAL OF CARDIOLOGY |
| 2024 | Treat-to-target or high-intensity statin treatment in older adults with coronary artery disease: a post hoc analysis of the LODESTAR trial | AGE AND AGEING |
| 2024 | Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention | JAMA CARDIOLOGY |
| 2024 | Moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING trial | DIABETES OBESITY & METABOLISM |
| 2024 | Impact of hypertriglyceridaemia on cardiovascular mortality according to low-density lipoprotein cholesterol in a 15.6-million population | EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY |
| 2024 | Comparison of Intracardiac Echocardiography Versus Transesophageal Echocardiography for Guidance During Transcatheter Aortic Valve Replacement
| KOREAN CIRCULATION JOURNAL |
| 2024 | Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial | CIRCULATION |
| 2023 | Association Between Body Mass Index and Clinical Outcomes According to Diabetes in Patients Who Underwent Percutaneous Coronary Intervention
| KOREAN CIRCULATION JOURNAL |
| 2023 | Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING randomized trial | ATHEROSCLEROSIS |
| 2023 | Association of Prophylactic Distal Perfusion Cannulation With Mortality in Patients Receiving Venoarterial Extracorporeal Membrane Oxygenation | AMERICAN JOURNAL OF CARDIOLOGY |
| 2023 | Effect of moderate-intensity statin with ezetimibe combination vs. high-intensity statin therapy according to sex in patients with atherosclerosis
| SCIENTIFIC REPORTS |
| 2023 | Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial
| BMJ-BRITISH MEDICAL JOURNAL |
| 2023 | Perioperative Antiplatelet Strategy in Patients Undergoing Noncardiac Surgery Within One Year After Percutaneous Coronary Intervention | AMERICAN JOURNAL OF MEDICINE |
| 2023 | Treat-to-target versus high-intensity statin treatment in patients with or without diabetes mellitus: a pre-specified analysis from the LODESTAR trial
| ECLINICALMEDICINE |
| 2023 | Efficacy of Percutaneous Coronary Intervention With Synergy Stents in Patients Aged ≥75 Years: 1-Year Clinical Outcomes from the Synergy Elderly Registry | AMERICAN JOURNAL OF CARDIOLOGY |
| 2023 | Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial | JAMA CARDIOLOGY |
| 2023 | Treating Coronary Artery Disease With Treat-to-Target or High-Intensity Statin-Reply | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION |
| 2023 | Angiotensin converting enzyme inhibitors versus angiotensin II type 1 receptor blockers in patients with acute myocardial infarction and prediabetes after successful implantation of newer-generation drug-eluting stents
| CARDIOLOGY JOURNAL |
| 2023 | Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY |
| 2023 | Sex Differences in Outcomes of Ticagrelor Therapy With or Without Aspirin After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY |
| 2023 | Dual antiplatelet therapy after percutaneous coronary intervention for left main coronary artery disease | REVISTA ESPANOLA DE CARDIOLOGIA |
| 2023 | Up-to-Date Clinical Practice in Percutaneous Coronary Intervention for Multivessel Disease
| JACC: Asia |
| 2023 | Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial
| ECLINICALMEDICINE |
| 2023 | Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY |
| 2023 | Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION |
| 2023 | Effects of Hypertension on Two-Year Outcomes According to Glycemic Status in Patients With Acute Myocardial Infarction Receiving Newer-Generation Drug-Eluting Stents | ANGIOLOGY |
| 2023 | Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials | EUROPEAN HEART JOURNAL |
| 2023 | Stent expansion evaluated by optical coherence tomography and subsequent outcomes
| SCIENTIFIC REPORTS |
http://orcid.org/0000-0003-4893-039X
(56328820500)
